Precigen
PGEN
$1.41
Share price
0.71%
Change (1 day)
16.53%
Change (1 year)
Categories
P/S ratio for Precigen (PGEN)
P/S ratio as of April 2024 (TTM): 56.4
According to Precigen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 56.3817. At the end of 2023 the company had a P/S ratio of 53.6.
P/S ratio history for Precigen from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 53.6 | 355.72% |
| 2022 | 11.8 | -14.34% |
| 2021 | 13.7 | -25.17% |
| 2020 | 18.3 | 68.26% |
| 2019 | 10.9 | 67.26% |
| 2018 | 6.52 | 7.29% |
| 2017 | 6.07 | -59.75% |
| 2016 | 15.1 | -25.51% |
| 2015 | 20.3 | -47.36% |
| 2014 | 38.5 | -60.87% |
| 2013 | 98.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 41.6 | -26.14% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | -69.13% | 🇬🇧 UK |
 Novavax NVAX | 0.8254 | -98.54% | 🇺🇸 USA |
 Novocure
NVCR | 2.67 | -95.27% | Jersey |